Saturday, 7 November 2026European Markets

MOTA ENGIL And SPIE Have A High Dividend Yield And Return On Equity In The Engineering & Construction Industry.

Loading stream...

(vianews) - mota engil (egl.ls) is among this list of stock assets with the highest dividend rate and return on equity on the engineering & construction industry.

financial asset price forward dividend yield return on equity
mota engil (egl.ls) €5.92 4.13% 15.88%
spie (spie.pa) €30.98 2.47% 8.32%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. mota engil (egl.ls)

4.13% forward dividend yield and 15.88% return on equity

mota-engil, sgps, s.a. provides construction and infrastructure management services in europe, africa, and latin america. its construction and infrastructure projects, including airports, railways, hydraulic, ports, roads, and urban facilities; and agricultural and industrial, public building, office and commerce, housing, and silo and chimney projects, as well as provides buildings rehabilitation services. the company also collects, treats, recovers, and disposes urban waste, and hazardous and non-hazardous; explores and prospects mineral resources; and generates and distributes electricity through hydro and bioenergy sources. in addition, it designs and constructs social housing; promotes and manages technological parks; develops real estate; and manages financial holdings. further, the company provides terminal exploration, inspection, business administration, commercial, sea transport, sustainable mobility, logistics, technical consultancy, engineering and architecture, tourism, road signs, and restaurant services; designs, constructs, manages, and exploits parking; rents construction equipment; manufactures and trades in clay materials; and operates industrial slaughterhouse. additionally, it is involved in construction and maintenance of amusement park; construction and public works; construction, renovation, and repair of residential buildings; exploring, extracting, drilling, pumping, supplying, and transporting of oil, gas, petroleum, and other related products; and stainless steel works, maintenance and operation of facilities, insurance mediation, and finance and consulting activities. the company was founded in 1946 and is headquartered in porto, portugal.

earnings per share

as for profitability, mota engil has a trailing twelve months eps of €0.19.

pe ratio

mota engil has a trailing twelve months price to earnings ratio of 31.16. meaning, the purchaser of the share is investing €31.16 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.88%.

more news about mota engil.

2. spie (spie.pa)

2.47% forward dividend yield and 8.32% return on equity

spie sa provides multi-technical services in the areas of energy and communications. the company operates through four segments: france; germany and central europe; north-western europe; and oil & gas and nuclear. it provides technical engineering solutions for buildings; technical facility management, energy-efficiency, and technical services for the transmission and distribution of energy for industrial clients; and electrical, mechanical, and hvac engineering services. the company also offers oil and gas services, including exploring and investigating new fields, buildings and operating facilities, and optimizing production; construction, renovation, and maintenance services for bridges, locks, and pumping stations; maintenance and innovative solutions for traffic infrastructure; and fixed and mobile digital telecom networks, as well as technical building management, communications and networks, tech fm services; engineering, construction, maintenance, and optimization services for industrial processes; energy recovery and sustainable management services to technical facilities; and energy transmission networks, medium-voltage facilities, distribution networks, busbar systems, and wind and solar power farms. in addition, it engages in the installation and maintenance of electrical systems, heating and air conditioning, building ventilation, utilities and automation for industries; and management of it and data processing infrastructures. the company was founded in 1900 and is headquartered in cergy-pontoise, france.

earnings per share

as for profitability, spie has a trailing twelve months eps of €0.93.

pe ratio

spie has a trailing twelve months price to earnings ratio of 33.31. meaning, the purchaser of the share is investing €33.31 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.32%.

volatility

spie's last week, last month's, and last quarter's current intraday variation average was a negative 0.24%, a positive 0.11%, and a positive 0.82%.

spie's highest amplitude of average volatility was 0.37% (last week), 0.61% (last month), and 0.82% (last quarter).

more news about spie.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com